Industry Partnerships
New Imaging Tools Could Reduce the Deadly Toll of Thrombus and Fibrosis
Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars in healthcare costs each year. Thrombus—the formation of blot clots—is the most common underlying pathology of ischemic heart disease, myocardial infarction, stroke and venous thromboembolism. Fibrosis—the formation of excess connective tissue…
Read More
Bayer Partners with Brigham Health and Mass General to Accelerate New Treatments for Lung Disease
Approximately 65 million people suffer from chronic obstructive pulmonary disease (COPD) worldwide, and three million people die from it each year. It is the third leading cause of disease-related death in the U.S. and a significant cause of long-term disability. The costs attributable to the disease are also staggering—from $32.1 billion in the U.S. in…
Read More
Partners Collaboration Supports Successful IPO for Health Catalyst
In many areas of disease, detection and early intervention are key tools in lessening the burden of disease and improving health outcomes for patients. The same approach is proving true at the population health level where identifying patients with chronic illnesses who are likely to become high-risk utilizers of medical services early on in their…
Read More
Nuance Collaboration Speeds AI Clinical Integration
If there has been a consistent message to come out of all the discussion about artificial intelligence (AI) in healthcare over the past few years it’s that in order to realize their vast potential, AI technologies must be able to fit seamlessly into existing clinical workflows. A new collaboration between Partners HealthCare and Nuance Communications,…
Read More
The Innovation Licensing Internship Program: Hands-on Experience in Commercializing Academic Research
Academic research is a vital source of novel technologies that improve our lives. Over 9 million people have been prescribed the blockbuster anti-seizure drug Lyrica, discovered at Northwestern University in 1989(1)Robbins, R. Why isn’t Harvard getting rich off its scientific research? STAT. December 21, 2015.(2)Lyrica FAQs. https://www.lyrica.com/frequently-asked-questions#how-many-people-have-been-prescribed-lyrica. Accessed 1/17/2018.. Other innovations originating from university research…
Read MoreMassCATS’s Unique Collaborative AD Research
Alzheimer’s disease has proven to be stubbornly difficult to diagnose and treat with six million individuals in the United States now estimated to suffer from it or a similar form of dementia. The problem could only get worse in the next few decades as the rates of those affected and the cost of care are…
Read MoreManaging Conflicts of Interests in its Interactions with Industry
A look at how Partners HealthCare handles interactions with industry to carry out its academic missions. Interactions with industry are essential to allowing Partners HealthCare to carry out its academic missions, but the financial interests that result must be carefully considered to avoid biases in patient care, research, and education. For decades Partners HealthCare has…
Read MorePrinted from https://innovationblog.partners.org/new-imaging-tools-could-reduce-the-deadly-toll-of-thrombus-and-fibrosis · Published 11 Dec 2019
© PARTNERS HEALTHCARE. ALL RIGHTS RESERVED